Verus Financial Partners, Inc. Merck & Co., Inc. Transaction History
Verus Financial Partners, Inc.
- $914 Million
- Q3 2024
A detailed history of Verus Financial Partners, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Verus Financial Partners, Inc. holds 3,513 shares of MRK stock, worth $356,991. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,513
Previous 3,487
0.75%
Holding current value
$356,991
Previous $431,000
7.66%
% of portfolio
0.04%
Previous 0.05%
Shares
18 transactions
Others Institutions Holding MRK
# of Institutions
3,824Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$25.4 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$21.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$12.1 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.7 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$6.01 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $257B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...